<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JBPC</journal-id><journal-title-group><journal-title>Journal of Biophysical Chemistry</journal-title></journal-title-group><issn pub-type="epub">2153-036X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jbpc.2010.13019</article-id><article-id pub-id-type="publisher-id">JBPC-3196</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Antioxidative action of N-a-tosyl-L-lysine chloromethyl ketone prevents death of glutathione-depleted cardiomyocytes induced by hydrogen peroxide
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>iyoshi</surname><given-names>Takahashi</given-names></name></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kyohei</surname><given-names>Oyama</given-names></name></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hironori</surname><given-names>Motoshige</given-names></name></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Koichi</surname><given-names>Sakurai</given-names></name><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><author-notes><corresp id="cor1">* E-mail:<email>ks51@hokuyakudai.ac.jp(KS)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>11</month><year>2010</year></pub-date><volume>01</volume><issue>03</issue><fpage>164</fpage><lpage>171</lpage><history><date date-type="received"><day>20</day>	<month>August</month>	<year>2010</year></date><date date-type="rev-recd"><day>22</day>	<month>September</month>	<year>2010</year>	</date><date date-type="accepted"><day>25</day>	<month>September</month>	<year>2010.</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Hydrogen peroxide (H
  <sub>2</sub>O
  <sub>2</sub>) induces the hypertrophy in cultured H9c2 cardiomyocytes and cell death in glutathione (GSH)-depleted H9c2 cells. In the present study, we observed that pretreatment with a serine protease inhibitor, N-a-tosyl-L-lysine chloromethyl ketone (TLCK), significantly prevented the H2O2-induced cell damages in GSH-depleted H9c2 cells in a concentration-dependent manner. The phase contrast microscopy revealed that although the exposure of the GSH-depleted H9c2 cells to H
  <sub>2</sub>O
  <sub>2</sub> resulted in a globular shape of the cells, TLCK prevented the occurrence of H
  <sub>2</sub>O
  <sub>2</sub>-induced morphological changes. TLCK also inhibited the generation of reactive oxygen species in the cells after addition of H
  <sub>2</sub>O
  <sub>2</sub>, suggesting that the antioxidant action of TLCK is involved in the protection against the cell damages by H
  <sub>2</sub>O
  <sub>2</sub>. Application of TLCK after ~30 min of exposure to H
  <sub>2</sub>O
  <sub>2</sub> could significantly protect the cells from cell damages. The other serine protease inhibitors that were tested could not prevent the cell damages in GSH- depleted H9c2 cells. Pretreatment with an inhibitor of nuclear factor-kB translocation into the nucleus and a proteasome inhibitor did not prevent the cell damages in GSH-depleted H9c2 cells. An inhibitor of p53 significantly prevented the cell damages in GSH-depleted H9c2 cells. These results suggest that antioxidative action of TLCK prevents the death of GSH-depleted H9c2 cardiomyocytes induced by H
  <sub>2</sub>O
  <sub>2</sub>.
 
</p></abstract><kwd-group><kwd>TLCK; Cardiomyocytes; Oxidative Damage; H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;; p53; ROS; Antioxidant</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. INTRODUCTION</title><p>Studies on the reactive oxygen species (ROS), such as superoxide, H<sub>2</sub>O<sub>2</sub>, and the hydroxyl radical, have indicated their involvement in pathogenesis of several diseases. Although ROS are involved in atherosclerosis, myocardial ischemia/reperfusion injury, and heart failure [1,2], the mechanism by which ROS initiate these diseases is not yet fully understood. In primary cultured neonatal rats cardiomyocytes, H<sub>2</sub>O<sub>2</sub> at higher doses causes necrotic cell death, whereas at lower doses, it induces apoptosis of a fraction of cells; the surviving cells undergo hypertrophy [<xref ref-type="bibr" rid="scirp.3196-ref3">3</xref>]. We had previously suggested that intracellular free thiol levels determine the fate of H<sub>2</sub>O<sub>2</sub>-treated H9c2 cardiomyocytes, i.e., cell death or hypertrophy [<xref ref-type="bibr" rid="scirp.3196-ref4">4</xref>]. In GSH-depleted H9c2 cells, hypertrophy did not occur after treatment with H<sub>2</sub>O<sub>2</sub> at any concentrations, but the viability of the cells decreased markedly in comparison with that of normal GSH-containing cells [<xref ref-type="bibr" rid="scirp.3196-ref4">4</xref>]. These findings suggest that the GSH-depleted cells are vulnerable to oxidative stress. It has been reported that GSH functions as an important cellular defense system against oxidative stress and that GSH participates in the detoxification reactions of free radicals and peroxides, either directly or indirectly as a coenzyme of antioxidant enzymes, such as glutathione peroxidases [5,6].</p><p>It is well known that the ratio of GSH to GSSG in cells represents the intracellular redox environment. Additionally, the intracellular redox state of GSH is involved in signal transduction through the redox regulation of a number of proteins that have critical thiols, such as receptors, proteins involved in ubiquitinylation, several protein kinases, and some transcription factors [7,8]. The modulation of the activity of several transcription factors, i.e., nuclear factor-kB (NF-kB), activator protein-1, and heat shock factor-1, by thiol redox state has been reviewed [<xref ref-type="bibr" rid="scirp.3196-ref5">5</xref>].</p><p>While caspases, a family of cysteine proteases, have been predominantly studied in cell death research, serine proteases may also play a significant role in cell death process [<xref ref-type="bibr" rid="scirp.3196-ref9">9</xref>]. The roles of these serine proteases, i.e., Omi /HtrA2, AP24, and thrombin, have been reviewed [<xref ref-type="bibr" rid="scirp.3196-ref10">10</xref>]. During the study that was conducted to clarify whether serine proteases might be involved in the H<sub>2</sub>O<sub>2</sub>-induced cell death in cardiomyocytes, we had the opportunity to determine the protective effect of N-a-tosyl-L-lysine chloromethyl ketone (TLCK), a well-known serine protease inhibitor, against the H<sub>2</sub>O<sub>2</sub>-induced cell damages in GSH-depleted cardiomyocytes. The serine protease inhibitors inhibited apoptosis-associated proteolysis and DNA fragmentation [<xref ref-type="bibr" rid="scirp.3196-ref9">9</xref>]. TLCK is recognized as an inhibitor of translocation of NF-kB [<xref ref-type="bibr" rid="scirp.3196-ref11">11</xref>] as well as an inhibitor of serine proteases. The translocation of NF-kB is involved in lipopolysaccharide-mediated cytotoxicity in macrophages, and the inhibition of this translocation by TLCK abrogated the cell death in macrophages [<xref ref-type="bibr" rid="scirp.3196-ref12">12</xref>]. Moreover, Gong et al. (1999) and Rideout et al. (2001) demonstrated that TLCK might interfere with p53 dependent cell death pathway [13,14]. Thus TLCK can exert its protective effect through various sites of action. The goal of the present study is to clarify the mechanism through which TLCK protects the GSH-depleted H9c2 cardiomyocytes against the H<sub>2</sub>O<sub>2</sub>-induced cell damages.</p></sec><sec id="s2"><title>2. MATERIALS AND METHODS</title><sec id="s2_1"><title>2.1. Chemicals</title><p>Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), L-buthionine (S, R) sulfoximine (BSO), TLCK, N-a-tosyl-L-phenylalanine chloromethyl ketone (TPCK), pifithrin-a, and catalase were obtained from Sigma Chemical Co., St. Louis, MO. SN50 and MG-132 were obtained from BIOMOL Research Laboratories, Inc., Plymouth Meeting, PA. Phenylmethanesulfonyl fluoride (PMSF) and H<sub>2</sub>O<sub>2</sub> were obtained from Wako Pure Chemical Industries, Ltd., Osaka, Japan. 4- (2-aminoethyl)-benzensulfonyl fluoride hydrochloride (AEBSF) was obtained from Roche Diagnostics GmbH, Mannheim, Germany. Leupeptin was obtained from Peptide Institute, Inc., Osaka, Japan. 2’,7’-dichlorofluorescin diacetate (DCFH<sub>2</sub>-DA) was purchased from CALBIOCHEM, San Diego, CA. The 3-[4,5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT) assay kit was obtained from Promega Co., Madison, WI. All the other chemicals used in this study were of the highest grade available from commercial suppliers.</p></sec><sec id="s2_2"><title>2.2. Culture and Treatment of Cells</title><p>Rat cardiomyocyte H9c2 cells were obtained from the American Type Culture Collection (Rockville, MD) and were grown in DMEM containing 10% (v/v) heatinactivated FBS. The cells were incubated in an atmosphere of 5% CO<sub>2</sub> and 95% air at 37&#176;C. The details of the standard treatment of H9c2 cells are as follows: the cells were seeded onto 96-well plates at a concentration of 1 x 10<sup>4</sup> cells/well for performing cell survival assays. After overnight preincubation with 0.1 mM BSO, the cells were incubated with different concentrations of H<sub>2</sub>O<sub>2 </sub>for various time intervals. TLCK and TPCK were usually added to the cell suspension concurrently with BSO unless otherwise noted, and the other inhibitors were added 30 min (leupeptin, PMSF, SN50) [<xref ref-type="bibr" rid="scirp.3196-ref15">15</xref>] or 1 h (AEBSF, MG-132, pifithrin-a) prior to the addition of H<sub>2</sub>O<sub>2</sub> [15-17]. The details regarding the intracellular GSH levels in H9c2 cells pretreated with or without BSO have been described in our previous report [<xref ref-type="bibr" rid="scirp.3196-ref4">4</xref>].</p></sec><sec id="s2_3"><title>2.3. Measurement of Cytotoxicity</title><p>Cell damages were determined using an MTT assay according to the manufacturer’s instructions. Briefly, after the incubation with H<sub>2</sub>O<sub>2</sub>, DMEM containing 10% FBS and a dye solution were added to each of the 96 wells and the assay plates were incubated for 4 h at 37&#176;C. A solubilization/stop solution was added for overnight incubation. The absorbances at 540 nm and 690 nm were recorded using a microplate reader (Labsystems Multiskan Bichromatic, Helsinki, Finland). Other culture conditions were same as those mentioned earlier. Cell morphology was investigated using a phase contrast microscope (Nikon Diaphoto-TMD, Tokyo, Japan).</p></sec><sec id="s2_4"><title>2.4. Measurement of Antioxidant Effect</title><p>Intracellular ROS levels were assessed using DCFH<sub>2</sub>- DA [18,19]. Briefly, DCFH<sub>2</sub>-DA was preincubated with cells in culture medium at a final concentration of 10 μM for 15 min. Following incubation with H<sub>2</sub>O<sub>2</sub> for 15 min, the cells were trypsinized, collected and washed with PBS by centrifugation at 300 &#180; g for 5 min. The cell pellets were resuspended with PBS (1 ml) and analyzed using a flow cytometer (Beckman Coulter, Fullerton, CA). DCF fluorescence was measured by fluorescence channel 1 of the flow cytometer [20,21]. Antioxidant effect of TLCK on lipid peroxidation was examined in rat liver microsomes incubated with ascorbic acid and FeCl<sub>3</sub> [<xref ref-type="bibr" rid="scirp.3196-ref22">22</xref>]. Briefly, microsomes (0.5 mg protein/mL) prepared from male Wistar strain rats were incubated with ascorbic acid (0.5 mM) and FeCl<sub>3</sub> (10 μM) in 50 mM phosphate buffer, pH 7.4 at 37&#176;C for 1 h. The production of lipid peroxidation was assessed using thiobarbituric acid reactive substance (TBARS). TLCK and TPCK were added to reaction system at the beginning of incubation. The TBARS values represented in the data was corrected by subtracting the value obtained in the reaction system without ascorbic acid and FeCl<sub>3</sub> from total value.</p></sec><sec id="s2_5"><title>2.5. Data Analysis</title><p>The data are expressed as mean &#177; SD of at least three experiments. Student’s t-test was used to analyze statistical difference. P values less than 0.05 were considered significant.</p></sec></sec><sec id="s3"><title>3. RESULTS</title><sec id="s3_1"><title>3.1. Protective Effects of TLCK against CellOxidative Damages by H<sub>2</sub>O<sub>2</sub></title><p>We had previously reported that H<sub>2</sub>O<sub>2</sub> induces hypertrophy in H9c2 cardiomyocytes and cell death in GSHdepleted H9c2 cells. An exposure to 100 &#181;M H<sub>2</sub>O<sub>2</sub> for more than 3 h induced an increase in the damages of the GSH-depleted H9c2 cells (<xref ref-type="fig" rid="fig1">Figure 1</xref>(a)), as assessed by the function of MTT reduction. The damages were inhibited by the addition of antioxidants such as Trolox and butylated hydroxyanisol (data not shown). H<sub>2</sub>O<sub>2</sub> (100 &#181;M) alone did not induce the damages in the cells pretreated without BSO. These results suggest that H<sub>2</sub>O<sub>2</sub> induces the oxidative damages in the GSH-depleted H9c2 cells. Pretreatment with TLCK significantly inhibited the cell damages induced by H<sub>2</sub>O<sub>2</sub> up to 6 h of test (<xref ref-type="fig" rid="fig1">Figure 1</xref>(a)). Although data not shown, the loss of MTT reductive activity was observed in the cells treated with H<sub>2</sub>O<sub>2</sub> for 24 h in the presence of TLCK, suggesting that TLCK prevented oxidative damages 6 h but dit not the cell death 24 h after the addition of H<sub>2</sub>O<sub>2</sub>. Therefore, we selected 6 h as the duration of H<sub>2</sub>O<sub>2</sub> treatment for the GSH-depleted cells in further experiments unless otherwise stated. Regarding the dose-related cytotoxic effect of H<sub>2</sub>O<sub>2</sub>, an increase in the concentration of H<sub>2</sub>O<sub>2</sub> resulted in an increase in the damages of the cells; however, TLCK significantly prevented H<sub>2</sub>O<sub>2</sub>-induced cell damages caused by ~250 &#181;M H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="fig1">Figure 1</xref>(b)). TLCK at a concentration of more than 30 &#181;M, particularly a concentration of 100 &#181;M, significantly prevented the cell damages induced by H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="fig1">Figure 1</xref>(c)). On the other hand, TLCK at a concentration of 300 &#181;M exerted a deleterious effect in a preliminary experiment (data not shown). Therefore, we selected 100 &#181;M TLCK as the dose in further experiments. An analysis using a phase contrast microscope was performed to observe the effect of TLCK on morphological changes in the H<sub>2</sub>O<sub>2</sub>-treated cells. Exposure to 100 &#181;M H<sub>2</sub>O<sub>2</sub> for 6 h resulted in a globular shape of the cells and detachment of the cells from the well in the GSH-depleted H9c2 cells (Figure</p><p>2(b)) in comparison with the H<sub>2</sub>O<sub>2</sub>-unexposed control cells (<xref ref-type="fig" rid="fig2">Figure 2</xref>(a)). Moreover, the cells remained attached had shrunken nuclei and cytoplasm (<xref ref-type="fig" rid="fig2">Figure 2</xref>(b)). When the cells were pretreated with TLCK, none of these morphological changes was observed in the cells even after incubation with H<sub>2</sub>O<sub>2</sub> for 6 h (<xref ref-type="fig" rid="fig2">Figure 2</xref>(c)), however, marked decrease of cell numbers was observed for 24 h. These results show that TLCK protects the GSH-depleted H9c2 cells against the H<sub>2</sub>O<sub>2</sub>-induced cell oxidative damages and morphological changes, but not the cell death.</p></sec><sec id="s3_2"><title>3.2. Effect of Addition Time of TLCK andCatalase on the Cell Damages Induced by H<sub>2</sub>O<sub>2</sub></title><p>TLCK was added to the GSH-depleted H9c2 cells at different time intervals before or after the addition of H<sub>2</sub>O<sub>2</sub>. TLCK could prevent the H<sub>2</sub>O<sub>2</sub>-induced cell damages when it was added to the cells at the same time as H<sub>2</sub>O<sub>2</sub>, 15 h before the addition of H<sub>2</sub>O<sub>2</sub>, or 0.5 h after the addition of H<sub>2</sub>O<sub>2</sub>. However, it could not prevent the cell damages when added 1 h after the addition of H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="fig3">Figure 3</xref>(a)). On the other hand, catalase completely prevented the cell damages when it was added at the same time as H<sub>2</sub>O<sub>2</sub>. However, it did not prevent cell damages when it was added 15 min after addition of H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="fig3">Figure 3</xref>(b)). These results suggest that H<sub>2</sub>O<sub>2</sub> induces the cell damages within 15 min after its addition and that TLCK may prevent the H<sub>2</sub>O<sub>2</sub>-induced cell damages by interfering with some steps in the signaling pathway that results in H<sub>2</sub>O<sub>2</sub>-induced cell damages, but not by quenching H<sub>2</sub>O<sub>2</sub>.</p></sec><sec id="s3_3"><title>3.3. Effects of Various Inhibitors on H<sub>2</sub>O<sub>2</sub>induced Cell Damages</title><p>To clarify the mechanism through which TLCK protects the GSH-depleted H9c2 cells against the H<sub>2</sub>O<sub>2</sub>- induced cell damages, we first tested whether inhibitors of serine protease other than TLCK could prevent the cell damages as with TLCK. The inhibitors tested in the present study included TPCK, leupeptin, PMSF, and AEBSF; and their test concentrations are shown in the <xref ref-type="fig" rid="fig4">Figure 4</xref>(a). None of these four inhibitors could protect the cells against the H<sub>2</sub>O<sub>2</sub>-induced cell damages; in fact, higher concentrations of TPCK and AEBSF exerted by themselves a deleterious effect on the ability of the cells for MTT reduction (<xref ref-type="fig" rid="fig4">Figure 4</xref>(a)). These results suggest that the protection of cells by TLCK against the H<sub>2</sub>O<sub>2</sub>-induced cell damages could not be due to its inhibitory effect on serine protease.</p><p>TLCK blocks the activation of NF-kB by inhibiting</p><p>the proteolytic cleavage of IkB, a cytosolic inhibitor of NF-kB. Accordingly, we examined the effects of SN50, an inhibitor of NF-kB translocation into the nucleus, and MG-132, a proteasome inhibitor that inhibits NF-kB activation by preventing IkB degradation, on the H<sub>2</sub>O<sub>2</sub>- induced cell damages. Neither SN50 nor MG-132 could protect the cells against the H<sub>2</sub>O<sub>2</sub>-induced cell damages; however, at higher concentrations, both the inhibitors had a little tendency to increase the damages of the control cells (<xref ref-type="fig" rid="fig4">Figure 4</xref>(b)). These results indicate that the protection of cells by TLCK against the H<sub>2</sub>O<sub>2</sub>-induced cell damages may not be mediated by the inhibition of NF-kB activation.</p><p>TLCK prevents neuronal cell death, which is induced by UV irradiation or by treatment with camptothecin, through the inhibition of the induction and nuclear accumulation of p53 [<xref ref-type="bibr" rid="scirp.3196-ref14">14</xref>]. H<sub>2</sub>O<sub>2</sub> induces phosphorylation of p53, leading to accumulation of p53 and transcription of its target gene p21<sup>Cip1/WAF1</sup> in endothelial cells [<xref ref-type="bibr" rid="scirp.3196-ref21">21</xref>]. If p53 participates in the H<sub>2</sub>O<sub>2</sub>-induced cell damages in our model, suppression of p53 should prevent the cell damages. Therefore, we examined the effect of pifithrin-a, an inhibitor of p53 [<xref ref-type="bibr" rid="scirp.3196-ref22">22</xref>], on the H<sub>2</sub>O<sub>2</sub>-induced cell damages. <xref ref-type="fig" rid="fig4">Figure 4</xref>(c) shows that pifithrin-a at a concentration of more than 5 &#181;M protected the GSH-depleted H9c2 cells against H<sub>2</sub>O<sub>2</sub>-induced cell damages in a concentration-dependent manner, and 20 &#181;M pifithrin-a almost completely blocked the cell damages. Pifithrin-a itself did not exert any deleterious effects on the ability of the cells for MTT reduction in the range of concentrations that were tested.</p></sec><sec id="s3_4"><title>3.4. Antioxidant Effects of TLCK</title><p>To evaluate the effect of TLCK on oxidative stress in the GSH-depleted H9c2 cells after the addition of H<sub>2</sub>O<sub>2</sub>, the generation of intracellular ROS was measured using a fluorescent probe DCFH<sub>2</sub>-DA. DCFH<sub>2</sub> reacts with ROS to generate a highly fluorescent derivative DCF [<xref ref-type="bibr" rid="scirp.3196-ref23">23</xref>]. As shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>(a), an increase in the intensity of DCF fluorescence was observed after the addition of H<sub>2</sub>O<sub>2</sub> in the GSH-depleted H9c2 cells, while TLCK significantly inhibited it after addition of H<sub>2</sub>O<sub>2</sub>. In the cells preincubated with BSO, TLCK does not affect the intensity of DCF fluorescence. TLCK did not induce the increase of GSH levels in the cells pretreated with BSO, or rather TLCK slightly decreased the level (16 &#177; 8.0%, p &gt; 0.05). To characterize the antioxidative action of TLCK, we evaluated the effect of TLCK on lipid peroxidation of rat liver microsomes in the reaction system of ascorbic acid and FeCl<sub>3</sub>. As shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>(b), TLCK significantly inhibited the production of TBARS in a dose-&#160; dependent manner. However, TPCK did not inhibit the</p><p>increase in production of TBARS, suggesting that TLCK may have some antioxidant action in the cells.</p></sec></sec><sec id="s4"><title>4. DISCUSSION</title><p>In our experiments, TLCK, which is known as an inhibitor of serine proteases, significantly protected GSHdepleted H9c2 cardiomyocytes from oxidative damages (<xref ref-type="fig" rid="fig1">Figure 1</xref>) and morphological changes (<xref ref-type="fig" rid="fig2">Figure 2</xref>) induced by H<sub>2</sub>O<sub>2</sub> up to 6 h of test, but did not from cell death for 24 h, suggesting that TLCK prevented the oxidative damages and delayed the induction of cell death. The other serine protease inhibitors, i.e., TPCK, leupeptin, PMSF, and AEBSF, did not exert any protective effect on the damages (<xref ref-type="fig" rid="fig4">Figure 4</xref>(a)); however, pharmacological inhibitors of serine proteases have been shown to prevent cell death under several other conditions [<xref ref-type="bibr" rid="scirp.3196-ref14">14</xref>]. These results suggest that serine proteases may not be involved in H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity of GSH-depleted cardiomyocytes. Therefore, we also investigated the other effects of TLCK on GSH-depleted H9c2 cardiomyocytes apart from the effect of serine protease inhibition.</p><p>The present study showed that pifithrin-a, an inhibitor of p53 function [<xref ref-type="bibr" rid="scirp.3196-ref23">23</xref>], significantly prevented the H<sub>2</sub>O<sub>2</sub>- induced cell damages (<xref ref-type="fig" rid="fig4">Figure 4</xref>(c)). The transcription factor p53, originally identified as a tumor suppressor protein, is activated in response to DNA damage, resulting in the induction of the transcription of the regulatory genes involved in cell cycle and DNA repair [<xref ref-type="bibr" rid="scirp.3196-ref24">24</xref>]. When DNA damage is serious and irreparable, p53 causes the cell death by inducing an apoptosis program in order to prevent formation of neoplasia in mammals [<xref ref-type="bibr" rid="scirp.3196-ref25">25</xref>]. It has also been demonstrated that oxidative stress is involved in the activation of p53 [<xref ref-type="bibr" rid="scirp.3196-ref26">26</xref>]. Gong et al. reported that TLCK prevented p53 induction and protected leukemic cells against ionizing radiation-induced cell death [<xref ref-type="bibr" rid="scirp.3196-ref13">13</xref>]. Rideout et al. also reported that TLCK prevented the induction and accumulation of p53 that was induced by DNA damage in cortical neurons, leading to the increase in the survival of the cells [<xref ref-type="bibr" rid="scirp.3196-ref14">14</xref>]. In the present study, pifithrin-a exerted a protective effect on the damages, suggesting the involvement of the p53-dependent pathway in the cytotoxicity. It has also been reported that TLCK prevents the activation of NF-kB through the inhibition of IkBa-protease [11,27]. We demonstrated that SN50, an inhibitor of translocation of NF-kB into nucleus, and MG-132, an inhibitor of proteasome that is responsible for the proteolysis of IkBa, did not protect the cells against the cytotoxicity. This result suggests that activation of NF-kB is not involved in the cell damage process.</p><p>Pretreatment with BSO presumably decreases the ability of cells to scavenge ROS, because BSO inhibits de novo synthesis of intracellular GSH [4,28]. The present data showed that an increase in the intensity of DCF fluorescence was observed after the addition of H<sub>2</sub>O<sub>2</sub> on BSOpretreated cells, suggesting that ROS are concerned with the cell damages. TLCK markedly inhibited the generation of ROS in the cells after addition of H<sub>2</sub>O<sub>2</sub>, and the production of TBARS in rat liver microsomes incubated with ascorbic acid and FeCl<sub>3</sub>. However, the levels of GSH in the cells pretreated with BSO were not significantly affected by the addition of TLCK. These results suggest that TLCK have the ability to scavenge ROS.</p><p>We had previously demonstrated that H<sub>2</sub>O<sub>2</sub> induces the hypertrophy in the normal (BSO-nontreated) cells and cell death in the GSH-depleted cells, suggesting that the intracellular free thiol levels determine the signal pathway resulting in the cell death or hypertrophy in H<sub>2</sub>O<sub>2</sub>-treated cardiomyocytes [<xref ref-type="bibr" rid="scirp.3196-ref4">4</xref>]. We demonstrated that TLCK did not induce the increase of GSH levels in H9c2 cells pretreated with BSO. These results suggest that neither the increase of GSH levels in the cells nor the interfering with the depletion of GSH by the pretreatment with BSO are involved in the protective action of TLCK on the oxidative damages. In addition, TLCK significantly inhibited the microsomal lipid peroxidation in the reaction system of ascorbic acid with FeCl<sub>3</sub>. We guess that rich electrons on 3- and 5-position of benzene ring and/or the primary amino group can participate in the protective action of TLCK against the production of TBARS and the oxidative damage(s) in the cells.</p><p>The H<sub>2</sub>O<sub>2</sub>-induced cell damages were abolished when catalase was added along with H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="fig3">Figure 3</xref>(b)), indicating that the cell damages are caused by the oxidative damages initiated by H<sub>2</sub>O<sub>2</sub>. After its addition, H<sub>2</sub>O<sub>2</sub> initiates the process of the cell damages within 15 min, because no cytoprotection was observed when catalase was added 15 min after the addition of H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="fig3">Figure 3</xref>(b)). In contrast, TLCK prevented the cell damages even when it was added 30 min after the addition of H<sub>2</sub>O<sub>2</sub>; however, it did not prevent cell damages when added 1 h after the addition of H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="fig3">Figure 3</xref>(a)). These results suggest a possibility that TLCK also block the some signaling pathway involving p53, that is activated within 1 h after stimulation. Based on these results, we inferred that TLCK abrogated the H<sub>2</sub>O<sub>2</sub>-induced cell damages via the antioxidant effect accompanied by the inhibitory effect on p53 function under defined experimental conditions. Further investigations are required to clear the target molecules and the protective mechanism of TLCK in cardiomyocyte.</p></sec><sec id="s5"><title>5. ACKNOWLEDGEMENTS</title><p>We thank Mr. Ryota Fujiki for helping with the measurement of GSH amounts.</p></sec><sec id="s6"><title>REFERENCES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.3196-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takano</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> Zou</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> Hasegawa</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> Akazawa</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> Nagai</surname><given-names> T. and Komuro</given-names></name>,<name name-style="western"><surname> I. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>Oxidative stress-induced signal transduction pathways in cardiac myocytes: Involvement of ROS in heart diseases</article-title><source> Antioxidants &amp; Redox Signaling</source><volume> 5</volume>,<fpage> 789</fpage>-<lpage>794</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref2"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Trachootham</surname><given-names> D.</given-names></name>,<name name-style="western"><surname> Lu</surname><given-names> W.</given-names></name>,<name name-style="western"><surname> Ogasawara</surname><given-names> M.A.</given-names></name>,<name name-style="western"><surname> Nilsa</surname><given-names> R.D. and Huang</given-names></name>,<name name-style="western"><surname> P. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2008</year>)<article-title>Redox regulation of cell survival</article-title><source> Antioxidants &amp; Redox Signaling</source><volume> 10</volume>,<fpage> 1343</fpage>-<lpage>1374</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Chen</surname><given-names> Q.M.</given-names></name>,<name name-style="western"><surname> Tu</surname><given-names> V.C.</given-names></name>,<name name-style="western"><surname> Wu</surname><given-names> Y. and Bahl</given-names></name>,<name name-style="western"><surname> J.J. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2000</year>)<article-title>Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes</article-title><source> Archives of Biochemistry and Biophysics</source><volume> 373</volume>,<fpage> 242</fpage>-<lpage>248</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref4"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Tanaka</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> Sakurai</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> Takahashi</surname><given-names> K. and Fujimoto</given-names></name>,<name name-style="western"><surname> Y. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>Requirement of intracellular free thiols for hydrogen peroxide-induced hypertrophy in cardiomyocytes</article-title><source> Journal of Cellular Biochemistry</source><volume> 89</volume>,<fpage> 944</fpage>-<lpage>955</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref5"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Arrigo</surname><given-names> A.P. </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>Gene expression and the thiol redox state</article-title><source> Free Radical Biology &amp; Medicine</source><volume> 27</volume>,<fpage> 936</fpage>-<lpage>944</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref6"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Carmel-Harel</surname><given-names> O. and Storz</given-names></name>,<name name-style="western"><surname> G. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2000</year>)<article-title>Roles of the glutathione- and thioredoxin-dependent reduction systems in the Escherichia coli and Saccharomyces cerevisiae responses to oxidative stress</article-title><source> Annual Review of Microbiology</source><volume> 54</volume>,<fpage> 439</fpage>-<lpage>461</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref7"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Filomeni</surname><given-names> G.</given-names></name>,<name name-style="western"><surname> Rotilio</surname><given-names> G. and Ciriolo</given-names></name>,<name name-style="western"><surname> M.R. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2002</year>)<article-title>Cell signaling and the glutathione redox system</article-title><source> Biochemical Pharmacology</source><volume> 64</volume>,<fpage> 1057</fpage>-<lpage>1064</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref8"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Shukla</surname><given-names> G.S.</given-names></name>,<name name-style="western"><surname> Shukla</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> Potts</surname><given-names> R.J.</given-names></name>,<name name-style="western"><surname> Osier</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> Hart</surname><given-names> B.A. and Chiu</given-names></name>,<name name-style="western"><surname> J.F. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2000</year>)<article-title>Cadmium-mediated oxidative stress in alveolar epithelial cells induces the expression of gamma-glutamylcysteine synthetase catalytic subunit and glutathione S-transferase alpha and pi isoforms: potential role of activator protein-1</article-title><source> Cell Biology and Toxicology</source><volume> 16</volume>,<fpage> 347</fpage>-<lpage>362</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref9"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Solary</surname><given-names> E.</given-names></name>,<name name-style="western"><surname> Eymin</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> Droin</surname><given-names> N. and Haugg</given-names></name>,<name name-style="western"><surname> M. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1998</year>)<article-title>Proteases, proteolysis, and apoptosis</article-title><source> Cell Biology and Toxicology</source><volume> 14</volume>,<fpage> 121</fpage>-<lpage>132</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref10"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Stenson-Cox</surname><given-names> C.</given-names></name>,<name name-style="western"><surname> FitzGerald</surname><given-names> U. and Samali</given-names></name>,<name name-style="western"><surname> A. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>In the cut and thrust of apoptosis, serine proteases come of age</article-title><source> Biochemical Pharmacology</source><volume> 66</volume>,<fpage> 1469</fpage>-<lpage>1474</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref11"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Kim</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> Lee</surname><given-names> H.S.</given-names></name>,<name name-style="western"><surname> Chang</surname><given-names> K.T.</given-names></name>,<name name-style="western"><surname> Ko</surname><given-names> T.H.</given-names></name>,<name name-style="western"><surname> Beak</surname><given-names> K.J. and Kwon</given-names></name>,<name name-style="western"><surname> N.S. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1995</year>)<article-title>Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-kappa B</article-title><source> The Journal of Immunology</source><volume> 154</volume>,<fpage> 4741</fpage>-<lpage>4748</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref12"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Abate</surname><given-names> A. and Schr?der</given-names></name>,<name name-style="western"><surname> H. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1998</year>)<article-title>Protease inhibitors protect macrophages from lipopolysaccharide-induced cytotoxicity: Possible role for NF-?B</article-title><source> Life Science</source><volume> 62</volume>,<fpage> 1081</fpage>-<lpage>1088</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref13"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Gong</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> Chen</surname><given-names> Q.</given-names></name>,<name name-style="western"><surname> Endlich</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> Mazumder</surname><given-names> S. and Almasan</given-names></name>,<name name-style="western"><surname> A. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>Ionizing radiation-induced, Bax-mediated cell death is dependent on activation of cysteine and serine proteases</article-title><source> Cell Growth &amp; Differentiation</source><volume> 10</volume>,<fpage> 491</fpage>-<lpage> 502</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref14"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Rideout</surname><given-names> H.J.</given-names></name>,<name name-style="western"><surname> Zang</surname><given-names> E.</given-names></name>,<name name-style="western"><surname> Yeasmin</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> Gordon</surname><given-names> R.</given-names></name>,<name name-style="western"><surname> Jabado</surname><given-names> O.</given-names></name>,<name name-style="western"><surname> Park</surname><given-names> D.S. and Stefanis</given-names></name>,<name name-style="western"><surname> L. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2001</year>)<article-title>Inhibitors of trypsin- like serine proteases prevent DNA damage-induced neuronal death by acting upstream of the mitochondrial checkpoint and of p53 induction</article-title><source> Neuroscience</source><volume> 107</volume>,<fpage> 339</fpage>-<lpage>352</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref15"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Adams</surname><given-names> J. and Stein</given-names></name>,<name name-style="western"><surname> R. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1996</year>)<article-title>Novel inhibitors of the proteasome and their therapeutic use in inflammation</article-title><source> Annual Reports in Medicinal Chemistry</source><volume> 31</volume>,<fpage> 279</fpage>-<lpage>288</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref16"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Grisham</surname><given-names> M.B.</given-names></name>,<name name-style="western"><surname> Palombella</surname><given-names> V.J.</given-names></name>,<name name-style="western"><surname> Elliott</surname><given-names> P.J.</given-names></name>,<name name-style="western"><surname> Conner</surname><given-names> E.M.</given-names></name>,<name name-style="western"><surname> Brand</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> Wong</surname><given-names> H.L.</given-names></name>,<name name-style="western"><surname> et al. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>Inhibition of NF-?B activation in vitro and in vivo: Role of 26S proteasome</article-title><source> Methods in Enzymology</source><volume> 300</volume>,<fpage> 345</fpage>-<lpage>363</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref17"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Chen</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> Albano</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> Ho</surname><given-names> A. and Keaney</given-names></name>,<name name-style="western"><surname> J.F.Jr. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>Activation of p53 by oxidative stress involves platelet-derived growth factor-? receptor-mediated ataxia telangiectasia mutated (ATM) kinase activation</article-title><source> The Journal of Biological Chemistry</source><volume> 278</volume>,<fpage> 39527</fpage>-<lpage>39533</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref18"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Setsukinai</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> Urano</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> Kakinuma</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> Majima</surname><given-names> H.J. and Nagano</given-names></name>,<name name-style="western"><surname> T. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species</article-title><source> The Journal of Biological Chemistry</source><volume> 278</volume>,<fpage> 3170</fpage>-<lpage>3175</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref19"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Gao</surname><given-names> D.</given-names></name>,<name name-style="western"><surname> Sakurai</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> Katoh</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> Chen</surname><given-names> J. and Ogiso</given-names></name>,<name name-style="western"><surname> T. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1996</year>)<article-title>Inhibition of microsomal lipid peroxidation by baicalein: A possible formation of an iron-baicalein complex</article-title><source> Biochemistry and Molecular Biology International</source><volume> 39</volume>,<fpage> 215</fpage>-<lpage>225</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref20"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Myhre</surname><given-names> O.</given-names></name>,<name name-style="western"><surname> Andersen</surname><given-names> J.M.</given-names></name>,<name name-style="western"><surname> Aarnes</surname><given-names> H. and Fonnum</given-names></name>,<name name-style="western"><surname> F. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>Evaluation of the probes 2',7'-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation</article-title><source> Biochemical Pharmacology</source><volume> 65</volume>,<fpage> 1575</fpage>-<lpage> 1582</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref21"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Stone</surname><given-names> J.R. and Yang</given-names></name>,<name name-style="western"><surname> S. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2006</year>)<article-title>Hydrogen peroxide: A signal messenger</article-title><source> Antioxidants &amp; Redox Signaling</source><volume> 8</volume>,<fpage> 243</fpage>-<lpage>270</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref22"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Lin</surname><given-names> Y.Z.</given-names></name>,<name name-style="western"><surname> Yao</surname><given-names> S.Y.</given-names></name>,<name name-style="western"><surname> Veach</surname><given-names> R.A.</given-names></name>,<name name-style="western"><surname> Torgerson</surname><given-names> T.R. and Hawiger</given-names></name>,<name name-style="western"><surname> J. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1995</year>)<article-title>Inhibition of nuclear translocation of transcription factor NF-?B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence</article-title><source> The Journal of Biological Chemistry</source><volume> 270</volume>,<fpage> 14255</fpage>-<lpage>14258</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref23"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Komarov</surname><given-names> P.G.</given-names></name>,<name name-style="western"><surname> Komarova</surname><given-names> E.A.</given-names></name>,<name name-style="western"><surname> Kondratov</surname><given-names> R.V.</given-names></name>,<name name-style="western"><surname> Christov-Tselkov</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> Coon</surname><given-names> J.S.</given-names></name>,<name name-style="western"><surname> Chernov</surname><given-names> M.V.</given-names></name>,<name name-style="western"><surname> et al. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy</article-title><source> Science</source><volume> 285</volume>,<fpage> 1733</fpage>-<lpage>1737</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref24"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Burns</surname><given-names> T.F. and El-Deiry</given-names></name>,<name name-style="western"><surname> W.S. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>The p53 pathway and apoptosis</article-title><source> Journal of Cellular Physiology</source><volume> 181</volume>,<fpage> 231</fpage>-<lpage> 239</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref25"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Chen</surname><given-names> S.J.</given-names></name>,<name name-style="western"><surname> Wang</surname><given-names> J.L.</given-names></name>,<name name-style="western"><surname> Chen</surname><given-names> J.H. and Huang</given-names></name>,<name name-style="western"><surname> R.N. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2002</year>)<article-title>Possible involvement of glutathione and p53 in trichloroethylene- and perchloroethylene-induced lipid peroxidation and apoptosis in human lung cancer cells</article-title><source> Free Radical Biology &amp; Medicine</source><volume> 33</volume>,<fpage> 464</fpage>-<lpage>472</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref26"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Renzing</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> Hansen</surname><given-names> S. and Lane</given-names></name>,<name name-style="western"><surname> D.P. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1996</year>)<article-title>Oxidative stress is involved in the UV activation of p53</article-title><source> Journal of Cell Science</source><volume> 109</volume>,<fpage> 1105</fpage>-<lpage>1112</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref27"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Henkel</surname><given-names> T.</given-names></name>,<name name-style="western"><surname> Machleidt</surname><given-names> T.</given-names></name>,<name name-style="western"><surname> Alkalay</surname><given-names> I.</given-names></name>,<name name-style="western"><surname> Kr?nke</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> Ben- Neriah</surname><given-names> Y. and Baeuerle</given-names></name>,<name name-style="western"><surname> P.A. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1993</year>)<article-title>Rapid proteolysis of I?B-? is necessary for activation of transcription factor NF-?B</article-title><source> Nature</source><volume> 365</volume>,<fpage> 182</fpage>-<lpage>185</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.3196-ref28"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Bai</surname><given-names> J. and Cederbaum</given-names></name>,<name name-style="western"><surname> A.I. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2006</year>)<article-title>Overexpression of CYP2E1 in mitochondria sensitizes HepG2 cells to the toxicity caused by depletion of glutathione</article-title><source> The Journal of Biological Chemistry</source><volume> 281</volume>,<fpage> 5128</fpage>-<lpage>5136</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref></ref-list></back></article>